Company Description
Allergan (NYSE: AGN) is a publicly traded pharmaceuticals: generic company in the Health Technology sector.
AGN stock has gained 37.8% over the past year.
This page provides a comprehensive overview of AGN stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
$—
0.00%
0.00
Last updated:
+37.82%
Performance 1 year
$0.0
329.8M
Allergan (AGN) stock. Over the past 12 months, the stock has gained 37.8%.
Latest News
Allergan has 6 recent news articles. Key topics include management, earnings. View all AGN news →
SEC Filings
Financial Highlights
—
Revenue (TTM)
—
Net Income (TTM)
—
Operating Cash Flow
Upcoming Events
Short Interest History
Last 12 Months
Days to Cover History
Last 12 Months
AGN Company Profile & Sector Positioning
Allergan (AGN) operates in the Pharmaceuticals: Generic industry within the broader Health Technology sector and is listed on the NYSE.